ARCH Venture Management, LLC

报告期 2026-03-31 · CIK 0001274403

持仓数

前50大市值合计

$677.1M

报告期

2026-03-31

当前持仓调仓

前 10 大持仓

标的

类型

市值

股数

占比*

MAZE MAZE THERAPEUTICS INC

COM

$123.0M

4,120,053

18.2%

RAPP RAPPORT THERAPEUTICS INC

COM

$116.7M

3,728,738

17.2%

VIR VIR BIOTECHNOLOGY INC

COM

$115.7M

12,916,663

17.1%

ERAS ERASCA INC

COM

$114.7M

7,091,557

16.9%

BEAM BEAM THERAPEUTICS INC

COM

$108.2M

4,540,132

16.0%

LYEL LYELL IMMUNOPHARMA INC

COM NEW

$65.1M

3,247,162

9.6%

GENB GENERATE BIOMEDICINES INC

COM SHS

$24.3M

1,944,426

3.6%

TXG 10X GENOMICS INC

CL A COM

$4.6M

217,834

0.7%

GOSS GOSSAMER BIO INC

COM

$2.6M

8,055,916

0.4%

QTTB Q32 BIO INC

COM

$2.1M

320,482

0.3%

* 占比按本页前 50 大持仓市值合计计算

持仓集中度按前 50 大市值

95%前 6 大占比

MAZE18.2%RAPP17.2%VIR17.1%ERAS16.9%BEAM16.0%LYEL9.6%